 BOSTON, May 11, 2021 PRNewswire -- Stealth BioTherapeutics Corp Nasdaq: MITO, a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that it will report first quarter 2021 financial results on Tuesday, May 18, 2021, before the market opens. Management will host a conference call at 8:30 am ET that day to discuss the financial results and provide a general business update. 